Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 9

1.

Relationship between Tumor Biomarkers and Efficacy in EMILIA, a Phase III Study of Trastuzumab Emtansine in HER2-Positive Metastatic Breast Cancer.

Baselga J, Lewis Phillips GD, Verma S, Ro J, Huober J, Guardino AE, Samant MK, Olsen S, de Haas SL, Pegram MD.

Clin Cancer Res. 2016 Aug 1;22(15):3755-63. doi: 10.1158/1078-0432.CCR-15-2499. Epub 2016 Feb 26. Erratum in: Clin Cancer Res. 2018 Nov 1;24(21):5486.

2.

Trastuzumab emtansine in human epidermal growth factor receptor 2-positive metastatic breast cancer: an integrated safety analysis.

Diéras V, Harbeck N, Budd GT, Greenson JK, Guardino AE, Samant M, Chernyukhin N, Smitt MC, Krop IE.

J Clin Oncol. 2014 Sep 1;32(25):2750-7. doi: 10.1200/JCO.2013.54.4999. Epub 2014 Jul 14.

PMID:
25024070
3.

A feasibility study to evaluate breast cancer patients' knowledge of their diagnosis and treatment.

Smith SM, Balise RR, Norton C, Chen MM, Flesher AN, Guardino AE.

Patient Educ Couns. 2012 Nov;89(2):321-9. doi: 10.1016/j.pec.2012.08.015. Epub 2012 Sep 30.

4.

Long-term outcome of patients with metastatic breast cancer treated with high-dose chemotherapy and transplantation of purified autologous hematopoietic stem cells.

Müller AM, Kohrt HE, Cha S, Laport G, Klein J, Guardino AE, Johnston LJ, Stockerl-Goldstein KE, Hanania E, Juttner C, Blume KG, Negrin RS, Weissman IL, Shizuru JA.

Biol Blood Marrow Transplant. 2012 Jan;18(1):125-33. doi: 10.1016/j.bbmt.2011.07.009. Epub 2011 Jul 20.

5.

Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility.

Telli ML, Hunt SA, Carlson RW, Guardino AE.

J Clin Oncol. 2007 Aug 10;25(23):3525-33. Review.

PMID:
17687157
6.

Phyllodes tumors of the breast: natural history, diagnosis, and treatment.

Telli ML, Horst KC, Guardino AE, Dirbas FM, Carlson RW.

J Natl Compr Canc Netw. 2007 Mar;5(3):324-30. Review.

PMID:
17439760
7.
8.
9.

A nonplatinum combination in metastatic transitional cell carcinoma.

Srinivas S, Guardino AE.

Am J Clin Oncol. 2005 Apr;28(2):114-8.

PMID:
15803002

Supplemental Content

Loading ...
Support Center